Navigation Links
Genstar Capital Promotes J. Ryan Clark to Principal
Date:2/11/2008

SAN FRANCISCO, Feb. 11 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of the life sciences and healthcare services, industrial technology, business services and software services, today announced that it has promoted J. Ryan Clark to Principal. Mr. Clark joined Genstar in 2004 and serves on the Boards of several Genstar portfolio companies, including Panolam Industries International, Inc., Fort Dearborn Company, PRA International, 21st Services, and Confie Seguros, the firm's most recent investment.

"Our people are the difference in our investments and as we continue to succeed in growing our portfolio of companies we are pleased to honor and recognize the achievements of our strong team of investment professionals," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "Ryan has contributed greatly to a number of our key investments since he joined the firm and has been instrumental in building out our information and insurance services practice. All of us at Genstar congratulate him and look forward to working him for many years."

Prior to joining Genstar, Ryan was an Associate at Hellman & Friedman LLC, a private equity investment firm. Previously, he worked in the Mergers, Acquisitions and Restructuring Department at Morgan Stanley in New York. Ryan earned an MBA from the Harvard Business School, and an AB in Environmental Science and Public Policy from Harvard College.

Mr. Clark will continue to develop investment opportunities in the information and insurance services industries and has led the firm's investment in 21st Services, a Minneapolis-based company that provides life expectancy information used in the life settlement industry, and also Confie Seguros, a platform company to consolidate insurance brokerages primarily focused on the Hispanic consumer.

About Genstar Capital, LLC

Genstar Capital

SOURCE Genstar Capital, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genstar Capital Appoints Mark Hanson to Managing Director
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. AtriCure to Present at Roth Capital Partners 2007 New York Conference
4. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
5. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
6. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
7. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
8. Pharsight Files Application for Nasdaq Capital Market Listing
9. Advanced Life Sciences Joins NASDAQ Capital Market
10. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
11. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)..., July 23 /PRNewswire/ -- Philip J. Dwyer, preside...offered testimony before the U.S.,Senate Health, E...tee on,Children and Families today to call for inc...s those implemented at YMCAs across the nation, th...n., Dwyer spoke on behalf of the more than 2,600 ...
(Date:7/23/2008)...vaccines for Immigration and Naturalization ready ..., BALTIMORE, July 23 /PRNewswire/ -- New vaccine ...r an immigrant visa for entry into the U.S. and,an...sidence. Applicants,must show proof of vaccination...nded by the U.S. Advisory Committee on Immunizatio...
(Date:7/23/2008)...DC - July 23, 2008) Biodiversity has long been rec...being. Humans rely on healthy ecosystems to provi...understood is the connection between disease and b...animals found in a geographic region). Recent stu...tect us against diseases such as Lyme disease and ...
(Date:7/23/2008)..., Pa., July 23 /PRNewswire-USNewswire/ -- The Chil...nounce a generous $15 million,gift that will enabl...rristown, Pennsylvania. This gift, made possible b... Pa, is one of the largest in the history of,Child...nd families in the,nearby communities convenient a...
Breaking Medicine News(10 mins):Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 2Health News:YMCA Calls on Senate to Fund Community-Based Solutions to Address Childhood Obesity Crisis 3Health News:USCIS Tightens Vaccination Requirements 2Health News:Could preserving biodiversity reduce disease? 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3
...o protect them against severe strains of the bacte...ontract a serious disease, according to a new stud...ed more than 740 children who lived in 16 diverse ...Results of the study show 28 percent of the childr...
...proved the survival of infants who are born weighi... these babies are at risk for school difficulties ...e prevalence of neurological, behavioral and intel...ren who were born in the early era of neonatal int...
...rts there will be more than 105,000 new cases of c...r diagnosed this year in the United States. When ...of side effects that make quality of life poor. No...l help them live better and with less stress. Clin...
...igation of sociocultural and political change //co... network of social scientists. It includes questio...ey are with their lives. It showed that average ha...in industrialized countries since World War II, al...
Other Medicine News:
(Date:7/23/2008)...23 /- Sound Pharmaceuticals (SPI) has...h the FDA for the clinical,testing of a proprietar...motherapy induced hearing loss or ototoxicity. The...e tested in advanced stage lung cancer,and head an...emotherapy.,This marks the second development prog...
(Date:7/23/2008)...3 /- FluoroPharma Inc., a company dev...the Positron Emission Tomography,(PET) market, ann...el,Fluorine-18 labeled tracer for myocardial perfu...ovascular product to complete Phase I clinical,dev... to assess the blood flow in the,heart (myocardial...
(Date:7/23/2008)... July 23 /- InCode BioPharmaceutics, ... announced preclinical test,results demonstrating ...,the treatment of the rare chronic blood disorder ...plete results will be presented at the XXII,Intern... September 28,2008., The only treatment currentl...
(Date:7/23/2008)...d on IND-Enabling Work with Protein Therapeutics t...lement System, CAMBRIDGE, Mass., July 23 /PRNewsw...it has initiated a corporate growth plan with the,...cutive officer and the,establishment of its headqu...oodruff Emlen, M.D., a co-founder of the company w...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3New nanotechnology television series does sweat the small stuff 3839 1New nanotechnology television series does sweat the small stuff 3839 2Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 1Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 2Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 3Jury Awards Mount Vernon Man 2440 1 Million After Medical Device Chars Heart 13974 4Helix BioPharma reports Q2 2008 highlights financial results 3838 1Helix BioPharma reports Q2 2008 highlights financial results 3838 2Helix BioPharma reports Q2 2008 highlights financial results 3838 3Helix BioPharma reports Q2 2008 highlights financial results 3838 4Helix BioPharma reports Q2 2008 highlights financial results 3838 5Helix BioPharma reports Q2 2008 highlights financial results 3838 6Helix BioPharma reports Q2 2008 highlights financial results 3838 7Helix BioPharma reports Q2 2008 highlights financial results 3838 8Helix BioPharma reports Q2 2008 highlights financial results 3838 9Helix BioPharma reports Q2 2008 highlights financial results 3838 10Helix BioPharma reports Q2 2008 highlights financial results 3838 11Helix BioPharma reports Q2 2008 highlights financial results 3838 12Helix BioPharma reports Q2 2008 highlights financial results 3838 13Late treatment with letrozole can reduce breast cancer recurrence risk 13972 1Late treatment with letrozole can reduce breast cancer recurrence risk 13972 2Late treatment with letrozole can reduce breast cancer recurrence risk 13972 3
...SS WIRE)--Jul 11, 2007 - Since the May,2007 releas...rt,that Avandia users are 43 percent more likely t... to die of cardiovascular causes,than non-users of...,to switch many type 2 diabetes patients from Avan...rch from GfK Market Measures,Event Flash, Physici...
...rontera AG (DSE: B8F) announces today,that it has ... part,of its phase IIb/III clinical trial started ...e active substance 5-aminolevulinic acid,(ALA) wit...icantly,superior to placebo in the treatment of ac...c therapy, which eliminates tumor tissue,through a...
Other Medicine Technology:Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 2Reaction to Avandia Warnings Stronger Among Internists Than,Endocrinologists, According to Study by GfK Market Measures 3Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy,of BF-200 ALA In Actinic Keratosis 2
...rist orthotic designed to limit the extension of t...g;,35° and 50°). , ,Indications: , Wrist...riangular fibrocartilage complex , Coles fractur...l tendon rupture , ORIF - Open reduction and int...
Contoured design provides secure support and immobilization of the wrist and distal forearm while preserving finger mobility
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
Medicine Products: